NEW YORK – What were the articles that gained the most interest from GenomeWeb readers last week? Here are the top five:
- Illumina Acquires Grail Despite Ongoing Regulatory Scrutiny
- Illumina's 'Maverick' Move Secures Grail Deal But Risks Loom
- Oxford Nanopore Technologies 2020 Revenues More Than Double
- Tempus Submits PMA Application for Tumor Profiling Assay to FDA
- European Commission to Investigate Illumina for Closing Grail Deal